The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Effort-based decision making is studied using tasks that offer choices between high-effort options leading to more highly valued reinforcers versus low-effort/low-reward options. These tasks have been used to study the involvement of neural systems, including mesolimbic dopamine and related circuits, in effort-related aspects of motivation. Moreover, such tasks are useful as animal models of some of the motivational symptoms that are seen in people with depression, schizophrenia, Parkinson’s disease, and other disorders. The present review will discuss the pharmacology of effort-related decision making and will focus on the use of these tasks for the development of drug treatments for motivational dysfunction. Research has identified pharmacological conditions that can alter effort-based choice and serve as models for depression-related symptoms (e.g., the vesicular monoamine transport-2 inhibitor tetrabenazine and proinflammatory cytokines). Furthermore, tests of effort-based choice have identified compounds that are particularly useful for stimulating high-effort work output and reversing the deficits induced by tetrabenazine and cytokines. These studies indicate that drugs that act by facilitating dopamine transmission, as well as adenosine A2A antagonists, are relatively effective at reversing effort-related impairments. Studies of effort-based choice may lead to the identification of drug targets that could be useful for treating motivational treatments that are resistant to commonly used antidepressants such as serotonin transport inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
Cuthbert, B. N., & Insel, T. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-126 · Cited by 3,053
The debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331 · cited 1×
“…motivational or motoric in nature because there is actually a fundamental overlap between activational aspects of motivation and movement control that has been recognized and discussed for decades (Mogenson et al., 1980; Salamone, 1992; Salamone and Correa, 2002, 2012; Salamone et al., 2017).”
BackgroundBerridge, K. C., & Robinson, T. E. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00233-9 · Cited by 1,869
Berridge, K. C., & Kringelbach, M. L. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.018 · Cited by 1,730
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579 · cited 1×
“…by a lack of behavioral activation that can be seen across several different disorders, including depression and schizophrenia (Salamone et al., 2006, 2015; Treadway and Zald, 2011; Barch et al., 2014; Dantzer et al., 2014; Whitton et al., 2015; Le Heron et al., 2017; De Doncker et al., 2018).”
BackgroundThe mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418 · cited 8×
“First and foremost, the term reward has no consistent scientific meaning (Salamone et al., 2005; Salamone and Correa, 2012), and, depending upon the paper, or even the paragraph, this term is used variously to refer to subjective pleasure or hedonic reactivity, appetite, preference, and even…”
BackgroundInfluentialSelf-citationThe Nucleus Accumbens: An Interface Between Cognition, Emotion, and Action
Floresco, S. B. (2015) · Annual Review of Psychology · doi:10.1146/annurev-psych-010213-115159 · Cited by 938 · cited 3×
“…human and animal studies has led to the development of formal animal models of motivational pathology that employ tasks assessing effort-based decision making (Salamone et al., 2006, 2015, 2016a,b,c; Simpson et al., 2011, 2012; Markou et al., 2013; Bailey et al., 2016; Der-Avakian et al., 2016).”
BackgroundSalamone, J. D., & Correa, M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00282-6 · Cited by 817
Self-citationCytokine, Sickness Behavior, and Depression
Dantzer, R. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.002 · Cited by 789
Wyvell, C. L., & Berridge, K. C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08122.2000 · Cited by 764 · cited 1×
“Furthermore, considerable evidence indicates that accumbens DA regulates Pavlovian approach behavior and the activating effects of Pavlovian-conditioned stimuli on instrumental behavior (Wyvell and Berridge, 2000; Parkinson et al., 2002; Lex and Hauber, 2008).”
BackgroundTreadway, M. T., Bossaller, N. A., Shelton, R. C., & Zald, D. H. (2012) · Journal of Abnormal Psychology · doi:10.1037/a0028813 · Cited by 733 · cited 4×
“This line of inquiry is validated by human studies showing that alterations in effort-based decision making are associated with depression (Treadway et al., 2012; Yang et al., 2014, 2016), schizophrenia (Gold et al.”
MethodInfluentialProlonged dopamine signalling in striatum signals proximity and value of distant rewards
Howe, M. W., Tierney, P. L., Sandberg, S. G., Phillips, P. E. M., & Graybiel, A. M. (2013) · Nature · doi:10.1038/nature12475 · Cited by 565
Zweifel, L. S., Parker, J. G., Lobb, C. J., Rainwater, A., Wall, V. Z., Fadok, J. P., Darvas, M., Kim, M. J., Mizumori, S. J. Y., Paladini, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813415106 · Cited by 426 · cited 2×
“For example, knockout of ventral tegmental N-methyl-D-aspartate receptors, which dramatically reduces phasic DA signaling, was reported to have no effect on PROG responding (Zweifel et al., 2009).”
BackgroundThe anatomy of apathy: a neurocognitive framework for amotivated behaviour
Le Heron, C., Apps., M. A. J., & Husain, M. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.07.003 · Cited by 380 · cited 1×
“…by a lack of behavioral activation that can be seen across several different disorders, including depression and schizophrenia (Salamone et al., 2006, 2015; Treadway and Zald, 2011; Barch et al., 2014; Dantzer et al., 2014; Whitton et al., 2015; Le Heron et al., 2017; De Doncker et al., 2018).”
BackgroundSalamone, J. D., Yohn, S. E., López-Cruz, L., San Miguel, N., & Correa, M. (2016) · Brain · doi:10.1093/brain/aww050 · Cited by 350 · cited 2×
“…A 2A receptor antagonists are so effective in reversing the effort-related effects of D2 antagonists because A 2A blockade directly attenuates the signal transduction effects of D2 antagonism in medium spiny neurons that colocalize both receptors (Farrar et al., 2010; Santerre et al., 2012).”
BackgroundMethodSelf-citationThe neuroimmune basis of fatigue
Dantzer, R., Heijnen, C. J., Kavelaars, A., Laye, S., & Capuron, L. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.10.003 · Cited by 346 · cited 4×
“…retardation, amotivation, and negative symptoms are used to describe a lack of behavioral activation that can be seen across a host of psychiatric and neurologic disorders, as well as various medical conditions, including inflammation (Stahl, 2002; Dantzer et al., 2014; Salamone et al., 2016a,c).”
BackgroundInfluentialBarch, D. M., Treadway, M. T., & Schoen, N. (2014) · Journal of Abnormal Psychology · doi:10.1037/a0036299 · Cited by 323
Amygdala-prefrontal cortical circuitry regulates effort based decision making
Floresco, S. B., & Ghods-Sharifi, S. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj143 · Cited by 316
Salamone, J. D. (1992) · Psychopharmacology · doi:10.1007/bf02245133 · Cited by 291
Self-citationDopamine enhances willingness to exert effort for reward in Parkinson's disease
Chong, T. T.-J., Bonnelle, V., Manohar, S., Veromann, K.-R., Muhammed, K., Tofaris, G. K., Hu, M., & Husain, M. (2015) · Cortex · doi:10.1016/j.cortex.2015.04.003 · Cited by 276 · cited 2×
“…is validated by human studies showing that alterations in effort-based decision making are associated with depression (Treadway et al., 2012; Yang et al., 2014, 2016; Culbreth et al., 2018), schizophrenia (Gold et al., 2013; Culbreth et al., 2018), and Parkinson ’ s disease (Chong et al., 2015).”
BackgroundAberman, J. E., & Salamone, J. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00004-4 · Cited by 263
Self-citationMiller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Cousins, M. S., Atherton, A., Turner, L., & Salamone, J. D. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00151-4 · Cited by 236 · cited 2×
“Similarly, DA-depleted rats tested on the T-maze barrier choice task showed deficits in barrier climbing when the no-barrier arm contained some food, but did not show significant reductions in barrier climbing when that was the only way to obtain food (Cousins et al., 1996; Yohn et al., 2015b).”
BackgroundSelf-citationBasal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229 · cited 1×
“…and other disorders, and there has been a particular focus on the association between cytokines and motivational symptoms such as anergia and fatigue (Capuron et al., 2007, 2009; Dantzer et al., 2008, 2012, 2014; Dantzer, 2009; Miller, 2009; Cattaneo et al., 2013; Felger and Treadway, 2016).”
BackgroundIncreasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation
Trifilieff, P., Feng, B., Urizar, E., Winiger, V, Ward, R. D., Taylor, K. M., Martinez, D., Moore, H., Balsam, P. D., Simpson, E. H., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.57 · Cited by 206 · cited 1×
“…with studies reporting that there is enhanced selection of high-effort instrumental actions in mice with knockdown of DA transporters (Cagniard et al., 2006), and in mice that have increased expression of DA D2 receptors in nucleus accumbens induced during adulthood (Trifilieff et al., 2013).”
BackgroundMesolimbic Dopamine and the Regulation of Motivated Behavior
Salamone, J. D., Pardo, M., Yohn, S. E., López-Cruz, L., SanMiguel, N., & Correa, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_383 · Cited by 204
Self-citationCapuron, L., Fornwalt, F. B., Knight, B. T., Harvey, P. D., Ninan, P. T., & Miller, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.017 · Cited by 164
Adenosine A1-A2A receptor heteromers: New targets for caffeine in the brain
Ferre, S. (2008) · Frontiers in bioscience · doi:10.2741/2852 · Cited by 149 · cited 1×
“Caffeine and other meth-ylxanthines such as theophylline and theobromine act as minor stimulants via their actions as nonselective antagonists of receptors (Ferré et al., 2008; Randall et al., 2011; Pardo et al., 2013; López-Cruz et al., 2014, 2016).”
BackgroundRavindran, A. V., Kennedy, S. H., O'Donovan, M. C., Fallu, A., Camacho, F., & Binder, C. E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0112 · Cited by 119 · cited 1×
“In this context, it is interesting to note that amphetamine, methylphenidate, and modafinil have been reported to have positive effects on motivational symptoms in patients with depression (Stotz et al., 1999; Lam et al., 2007; Ravindran et al., 2008).”
BackgroundWallace, M., Singer, G., Finlay, J., & Gibson, S. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90262-9 · Cited by 96 · cited 1×
“…can generate intense activities such as polydipsia, wheel running, and high levels of motor activity, and evidence indicates that DA antagonism and depletion of mesolimbic DA blunt these activities (Robbins and Koob, 1980; Wallace et al., 1983; Salamone, 1986, 1988; McCullough and Salamone, 1992).”
BackgroundRothschild, A. J., Raskin, J., Wang, C.-N., Marangell, L. B., & Fava, M. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.08.008 · Cited by 59
Stotz, G., Woggon, B., & Angst, J. (1999) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.1999.1.3/gstotz · Cited by 45 · cited 1×
“In this context, it is interesting to note that amphetamine, methylphenidate, and modafinil have been reported to have positive effects on motivational symptoms in patients with depression (Stotz et al., 1999; Lam et al., 2007; Ravindran et al., 2008).”
BackgroundSegovia, K. N., Correa, M., & Salamone, J. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.078 · Cited by 44 · cited 1×
“…several studies have reported an association between instrumental response output and pre-or postsynaptic markers of DA-related signaling (Sokolowski et al., 1998; Segovia et al., 2011, 2012; Howe et al., 2013; Saddoris et al., 2015; Hamid et al., 2016; Ko and Wanat, 2016; Wood et al., 2017).”
ResultSelf-citation
Cited by
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665
The physiological control of eating: signals, neurons, and networks
Watts, A. G., Kanoski, S. E., Sanchez-Watts, G., & Langhans, W. (2022) · Physiological Reviews · doi:10.1152/physrev.00028.2020 · Cited by 168
Ferré, S., Díaz-Ríos, M., Salamone, J. D., & Prediger, R. D. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0017 · Cited by 52
“This inconsistency and lack of agreement on the ‘‘optimal’’ dose of caffeine could be related to the general inability to monitor the A2AR gene polymorphisms that moderate the intake of coffee and caffeine.81 On the other hand, many studies have shown that caffeine treatment improved memory and attention deficits and…”
BackgroundResultInfluentialSelf-citationDisordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington’s Disease
Morris, L., O'Callaghan, C., & Le Heron, C. (2022) · Movement Disorders · doi:10.1002/mds.29013 · Cited by 36
“Importantly, the action of a given neurotransmitter can vary greatly depending on the specific receptors it acts on and the effects of other neuromodulators.(35) This imbues the brain with significant flexibility but presents a major challenge for scientists trying to advance understanding and develop pharmacological…”
Background
Metadata
- Authors
- Salamone, J. D., Correa, M., Ferrigno, S., Yang, J.-H., Rotolo, R. A., & Presby, R. E.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 70
- Issue
- 4
- Pages
- 747-762
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2890675907
- Cited by
- 100
- References
- 36
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.